ALKERMES PLC's ticker is ALKS and the CUSIP is G01767105. A total of 272 filers reported holding ALKERMES PLC in Q2 2022. The put-call ratio across all filers is 0.80 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $480,686,807 | -9.1% | 17,161,257 | +1.6% | 0.01% | -6.7% |
| Q2 2023 | $528,640,569 | +12.8% | 16,889,475 | +1.6% | 0.02% | +7.1% |
| Q1 2023 | $468,553,124 | +9.2% | 16,621,253 | +1.2% | 0.01% | +7.7% |
| Q4 2022 | $429,163,665 | +24.1% | 16,424,174 | +6.0% | 0.01% | +8.3% |
| Q3 2022 | $345,851,000 | -26.5% | 15,488,206 | -1.9% | 0.01% | -20.0% |
| Q2 2022 | $470,291,000 | +18.5% | 15,786,860 | +4.7% | 0.02% | +36.4% |
| Q1 2022 | $396,756,000 | +19.7% | 15,080,046 | +5.8% | 0.01% | +37.5% |
| Q4 2021 | $331,506,000 | -17.9% | 14,252,287 | +8.9% | 0.01% | -27.3% |
| Q3 2021 | $403,655,000 | +26.3% | 13,088,720 | +0.4% | 0.01% | +22.2% |
| Q2 2021 | $319,657,000 | +82.4% | 13,036,546 | +39.0% | 0.01% | +80.0% |
| Q1 2021 | $175,250,000 | -2.7% | 9,381,683 | +4.0% | 0.01% | -16.7% |
| Q4 2020 | $180,042,000 | +22.7% | 9,024,694 | +1.9% | 0.01% | +20.0% |
| Q3 2020 | $146,685,000 | -21.0% | 8,852,427 | -7.5% | 0.01% | -28.6% |
| Q2 2020 | $185,627,000 | +46.9% | 9,565,944 | +9.2% | 0.01% | +16.7% |
| Q1 2020 | $126,366,000 | -32.2% | 8,763,207 | -4.1% | 0.01% | -14.3% |
| Q4 2019 | $186,442,000 | -4.5% | 9,139,373 | -8.7% | 0.01% | -12.5% |
| Q3 2019 | $195,315,000 | -22.2% | 10,011,049 | -10.1% | 0.01% | -27.3% |
| Q2 2019 | $251,050,000 | -31.8% | 11,137,923 | +10.4% | 0.01% | -31.2% |
| Q1 2019 | $368,006,000 | +23.8% | 10,085,082 | +0.1% | 0.02% | +6.7% |
| Q4 2018 | $297,341,000 | -29.7% | 10,075,972 | +1.1% | 0.02% | -16.7% |
| Q3 2018 | $423,004,000 | +3.2% | 9,967,120 | +0.1% | 0.02% | -5.3% |
| Q2 2018 | $409,822,000 | -32.0% | 9,956,811 | -4.3% | 0.02% | -34.5% |
| Q1 2018 | $602,830,000 | +4.2% | 10,400,814 | -1.6% | 0.03% | +3.6% |
| Q4 2017 | $578,405,000 | +7.2% | 10,568,319 | -0.4% | 0.03% | +3.7% |
| Q3 2017 | $539,603,000 | -8.9% | 10,613,743 | +3.9% | 0.03% | -12.9% |
| Q2 2017 | $592,381,000 | -1.6% | 10,218,765 | -0.7% | 0.03% | -6.1% |
| Q1 2017 | $602,115,000 | +6244.1% | 10,292,601 | +5927.5% | 0.03% | +153.8% |
| Q4 2016 | $9,491,000 | +29.3% | 170,762 | +9.4% | 0.01% | +18.2% |
| Q3 2016 | $7,342,000 | +12.2% | 156,113 | +3.1% | 0.01% | +10.0% |
| Q2 2016 | $6,541,000 | +0.7% | 151,352 | -20.3% | 0.01% | 0.0% |
| Q1 2016 | $6,495,000 | -60.2% | 189,989 | -7.5% | 0.01% | -58.3% |
| Q4 2015 | $16,310,000 | -0.3% | 205,461 | -26.3% | 0.02% | -7.7% |
| Q3 2015 | $16,360,000 | -20.4% | 278,866 | -12.7% | 0.03% | -13.3% |
| Q2 2015 | $20,542,000 | -16.9% | 319,277 | -21.3% | 0.03% | -11.8% |
| Q1 2015 | $24,722,000 | +5.0% | 405,482 | +0.8% | 0.03% | 0.0% |
| Q4 2014 | $23,554,000 | +12.7% | 402,214 | -17.5% | 0.03% | +9.7% |
| Q3 2014 | $20,902,000 | -33.7% | 487,567 | -22.2% | 0.03% | -34.0% |
| Q2 2014 | $31,546,000 | +8.8% | 626,792 | -4.7% | 0.05% | 0.0% |
| Q1 2014 | $28,990,000 | +68.8% | 657,512 | +55.6% | 0.05% | +67.9% |
| Q4 2013 | $17,179,000 | +608.7% | 422,506 | +486.0% | 0.03% | +460.0% |
| Q3 2013 | $2,424,000 | +15.9% | 72,097 | -1.1% | 0.01% | +25.0% |
| Q2 2013 | $2,091,000 | – | 72,908 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 8,964,640 | $234,246,043 | 27.88% |
| Krensavage Asset Management, LLC | 1,401,783 | $36,629 | 11.32% |
| Hardman Johnston Global Advisors LLC | 5,561,806 | $145,329,991 | 5.69% |
| 13D Management LLC | 383,584 | $10,023,050 | 5.27% |
| Prosight Management, LP | 341,521 | $8,923,944 | 4.87% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 593,000 | $15,483,230 | 4.78% |
| Tamarack Advisers, LP | 275,000 | $7,185,750 | 3.70% |
| Ally Bridge Group (NY) LLC | 142,002 | $3,710,512 | 3.61% |
| HealthCor Management, L.P. | 110,000 | $2,874,300 | 2.63% |
| Price Jennifer C. | 360,600 | $9,422,478 | 2.25% |